吸入麻醉市場規模、佔有率和成長分析（按藥物、最終用戶和地區）：產業預測（2024-2031）

2022年全球吸入麻醉市場規模約14.6億美元，高於2023年的16億美元，在預測期內（2024-2031年）複合年成長率為9.4%，預計將在2022年達到32.8億美元。 2031.

由於幾個重要因素，吸入麻醉市場預計在未來幾年將顯著成長。慢性病盛行率的上升和醫療機構對麻醉的需求不斷增加預計將顯著促進吸入麻醉產品的銷售。此外，全球外科手術的增加在分析期間及之後對吸入麻醉的需求增加起著關鍵作用。麻醉技術的創新和對先進麻醉技術開發的增加投資正在為市場擴張開闢新的途徑。此外，老年人口的增加以及對專門兒科麻醉的需求不斷增加將進一步促進吸入麻醉市場的長期成長。然而，從長遠來看，與麻醉相關的潛在健康併發症、熟練麻醉師的短缺以及與先進麻醉輸送系統相關的高成本等挑戰可能會阻礙吸入麻醉市場的需求。總體而言，儘管存在需要克服的障礙，但吸入麻醉的整體前景仍然樂觀，醫療領域存在許多成長和創新的機會。

目錄

介紹

• 分析目的
• 定義
• 市場範圍

分析方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價值鏈分析
• 案例研究分析
• 監管環境
• 技術分析

吸入麻醉市場：依藥物分類

• 市場概況
• SEVOFLURANE
• DESFLURANE
• Isoflurane
• 其他

吸入麻醉市場：依應用分類

• 市場概況
• 就職
• 維持

吸入麻醉市場：依最終用途分類

• 市場概況
• 醫院
• 門診手術中心
• 其他

吸入麻醉市場：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲 (MEA)
  • 波灣合作理事會(GCC) 國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• 百特國際公司（美國）
• Halocarbon 產品公司（美國）
• 皮拉馬爾重症監護（印度）
• 艾伯維公司（美國）
• 費森尤斯卡比股份公司（德國）
• GE醫療集團（美國）
• Hikma Pharmaceuticals PLC（英國）
• 林德公司（愛爾蘭）
• Dragerwerk AG & Co. KGaA（德國）
• 邁瑞醫療國際有限公司 (中國)
• 深圳市陸風實業有限公司 (中國)
• 美敦力公司（愛爾蘭）
• 美敦力公司（愛爾蘭）
• 史密斯Group Limited（英國）
• 泰利福公司（美國）
• Masimo 公司（美國）
• 潘隆有限公司（英國）
• Dameca A/S（丹麥）
• 索瑪科技有限公司（美國）
• 納朗醫療有限公司（印度）

Global Inhalation Anesthesia Market size was valued at around USD 1.46 billion in 2022 and is expected to rise from USD 1.60 billion in 2023 to reach a value of USD 3.28 billion by 2031, at a CAGR of 9.4% over the forecast period (2024-2031).

The inhalation anesthesia market is poised for substantial growth in the coming years, driven by several key factors. The rising prevalence of chronic diseases and an increasing demand for anesthesia in healthcare facilities are expected to significantly boost sales of inhalation anesthesia products. Additionally, the global uptick in surgical procedures plays a pivotal role in elevating the demand for inhalation anesthesia throughout the study period and beyond. Innovations in anesthetic technologies and heightened investments in developing advanced anesthetic techniques are opening new avenues for market expansion. Furthermore, the growing geriatric population, alongside the rising need for specialized pediatric anesthesia, will further contribute to the long-term growth of the inhalation anesthesia market. However, challenges such as potential health complications associated with anesthesia, a shortage of skilled anesthesiologists, and the high costs associated with advanced anesthesia delivery systems may hinder market demand in the long run. Overall, while there are obstacles to navigate, the overall outlook for inhalation anesthesia remains positive, with numerous opportunities for growth and innovation in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inhalation Anesthesia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inhalation Anesthesia Market Segmental Analysis

Global Inhalation Anesthesia Market is segmented by Drug, Application End Use and region. Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Induction, and Maintenance. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Inhalation Anesthesia Market

The escalating prevalence of chronic diseases worldwide is driving a rising number of surgical procedures, significantly influencing the Global Inhalation Anesthesia market. As surgical interventions become increasingly common, the demand for effective and safe anesthesia options-such as inhalation agents-grows correspondingly. This trend highlights the essential role of anesthesia in facilitating complex surgeries and improving patient outcomes. Furthermore, advancements in inhalation anesthesia technologies and increasing awareness of their benefits enhance their adoption across healthcare settings. As healthcare systems adapt to address the surge in surgical needs, the inhalation anesthesia market is poised for substantial growth, creating lucrative opportunities for stakeholders.

Restraints in the Global Inhalation Anesthesia Market

One of the significant market restraints for the Global Inhalation Anesthesia market is the declining number of skilled anesthesiologists proficient in administering inhalation anesthesia. As the demand for surgical procedures rises globally, the shortage of qualified professionals willing and able to operate advanced anesthesia systems may hinder the effective implementation of inhalation anesthesia techniques. This scarcity is especially pronounced in underdeveloped and developing regions, where healthcare infrastructure may be lacking. Consequently, the insufficient pool of skilled anesthesiologists poses a barrier to market growth by limiting the accessibility and utilization of inhalation anesthesia, thereby potentially impacting patient outcomes and overall market expansion.

Market Trends of the Global Inhalation Anesthesia Market

The Global Inhalation Anesthesia market is witnessing a significant trend towards sustainable anesthetic agents, driven by increasing environmental awareness and stringent regulatory mandates. Manufacturers are prioritizing the development of inhalation anesthetics that minimize ecological impact, aligning with global sustainability goals. This shift not only addresses growing concerns about greenhouse gas emissions associated with traditional anesthetics but also positions companies favorably in a competitive landscape. By innovating in eco-friendly anesthetic formulations and practices, businesses can enhance their market presence and appeal to environmentally conscious healthcare providers, ultimately reshaping the future dynamics of the inhalation anesthesia industry.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Case Study Analysis
• Regulatory Landscape
• Technology Analysis

Inhalation Anesthesia Market, By Drug

• Market Overview
• Sevoflurane
• Desflurane
• Isoflurane
• Others

Inhalation Anesthesia Market, By Application

• Market Overview
• Induction
• Maintenance

Inhalation Anesthesia Market, By End-Use

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Healthcare Analytical Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Halocarbon Products Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Critical Care (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linde Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dragerwerk AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Landwind Industry Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith's Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penlon Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dameca A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soma Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Narang Medical Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments